The Partnership’s mission is to assist developing countries in introducing seasonal influenza vaccines and implementing sustainable programs to protect high-risk individuals from morbidity and mortality associated with annual influenza epidemics.
The Partnership provides influenza vaccine and supplies to countries that lack those resources but are otherwise ready to establish or expand their influenza vaccination programs.
The Partnership also advises on evaluation of influenza vaccination programs and sustainability planning for those programs.
The Partnership for Influenza Vaccine Introduction (PIVI) began as an innovative collaboration between Government of Laos People’s Democratic Republic, Walgreens Company, U.S. Centers for Disease Control and Prevention (CDC), World Health Organization (WHO) Country Office in Laos, and United Parcel Service (UPS).
As a direct result of the collaboration and a donation of influenza vaccine to Laos by Walgreens Company, Laos was able to conduct its first-ever seasonal influenza vaccination campaign in spring of 2012.
The following year (2013), the Government of Nicaragua joined the project and Walgreens Company, UPS, bioCSL, Becton Dickinson and Company (BD), and the U.S. Department of Defense Air Force each gave resources.
Thanks to donor contributions, in 2013 Laos held its second seasonal influenza vaccination campaign, and Nicaragua expanded its existing vaccination program to include more pregnant women.
The project was highlighted as a promising strategy for global vaccine security by WHO, and was honored with the 2011 CDC Director’s Award for Innovation – presented by CDC Director Dr. Thomas Frieden – in August 2012.